
US-based sterile injectable manufacturer, American Injectables, produces ready-to-use syringes and vials, serving as a strategic pharma partner.
American Injectables, founded in Brooksville, FL, is a US-based manufacturer specializing in sterile injectable medications. The company focuses on producing ready-to-use pre-filled syringes and vials, aiming to reduce dependency on foreign suppliers from India and China. Their product pipeline includes small molecule 505(b)(2) NDA and 505(j) ANDA syringe and vial products. Additionally, American Injectables serves as an outsourced contract manufacturing partner for strategic pharmaceutical companies, ensuring high-quality and dependable supply chains.
Notable figures affiliated with American Injectables include key leadership from experienced professionals in the pharmaceutical manufacturing industry. The company has attracted significant attention for its commitment to domestic production, contributing to national healthcare security. Its achievements include the successful development and commercialization of critical injectable products, which have had a substantial impact on the availability and reliability of essential medications in the US market.
Companies similar to American Injectables include US Specialty Formulations, ApiJect Systems, Dawah Pharmaceuticals and Amphastar Pharmaceuticals.
American Injectables was founded in 2020.
American Injectables' headquarters is located in Brooksville, FL, US.
American Injectables' most recent funding round was for $10M (USD) in September 2020.
As of Sep 24, 2020, American Injectables has disclosed funding of $10M (USD). Undisclosed round amounts are excluded.
American Injectables has 67 employees as of Feb 4, 2024.
Amphastar Pharmaceuticals
amphastar.com